ABLI THERAPEUTICS INC — Federal Contracts, Awards & Government Contractor Profile

About ABLI THERAPEUTICS INC

ABLi Therapeutics, Inc. is a biotechnology company focused on developing small molecule inhibitors targeting Abelson Tyrosine Kinases (Abl kinases) to treat neurodegenerative diseases such as Parkinson’s disease. The company utilizes its proprietary RAMP™ drug innovation engine to design novel product candidates with enhanced brain penetration, potency, and safety.

Development of small molecule inhibitors targeting Abl kinasesUtilization of RAMP™ drug innovation engine for enhanced brain penetration and safetyEngineering of Abl kinase inhibitors for neurodegenerative diseasesDesign of disease-modifying therapies for Parkinson’s disease and related conditions

Is this your company?

Claim ABLI THERAPEUTICS INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim ABLI THERAPEUTICS INC & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.